Zoetis, Inc. is the producer of medicine and vaccinations for pets and livestock. The Company has a diversified business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within five major product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Company Growth (employees)
Type
Public
HQ
Parsippany Troy Hills, US
Founded
1952
Size (employees)
9,000 (est)
Website
zoetis.com
Zoetis was founded in 1952 and is headquartered in Parsippany-Troy Hills, US

Zoetis Office Locations

Zoetis has an office in Parsippany-Troy Hills
Parsippany-Troy Hills, US (HQ)
10 Sylvan Way

Zoetis Financials and Metrics

Zoetis Financials

Zoetis's revenue was reported to be $4.9 b in FY, 2016
USD

Revenue (Q2, 2017)

1.3 b

Gross profit (Q2, 2017)

829 m

Gross profit margin (Q2, 2017), %

65%

Market capitalization (13-Nov-2017)

33.9 b

Cash (07-Feb-2017)

705 m

EV

34.1 b
Zoetis's current market capitalization is $33.9 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

4.6 b4.8 b4.8 b4.9 b

Revenue growth, %

5%(0%)3%

Cost of goods sold

1.7 b1.7 b1.7 b

Gross profit

2.9 b3.1 b3.2 b
USDQ2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017

Revenue

1.2 b1.2 b1.2 b1.2 b1.2 b1.3 b1.2 b1.3 b

Cost of goods sold

427 m421 m410 m389 m399 m435 m443 m440 m

Gross profit

748 m793 m831 m773 m809 m912 m788 m829 m

Gross profit Margin, %

64%65%67%67%67%68%64%65%
USDFY, 2016

Cash

727 m

Accounts Receivable

34.6 m

Inventories

1.5 b

Current Assets

3.4 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017

Cash

544 m592 m651 m675 m658 m2 b629 m705 m

Inventories

1.4 b1.4 b1.6 b1.5 b1.5 b1.5 b1.5 b1.5 b

Current Assets

3.3 b3.5 b3.4 b3.3 b3.3 b4.9 b3.4 b3.6 b

Goodwill

1.2 b1.2 b1.5 b1.5 b1.5 b1.5 b1.5 b1.5 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

819 m

Depreciation and Amortization

60 m60 m85 m

Accounts Receivable

15 m

Inventories

(101 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017

Depreciation and Amortization

15 m15 m21 m21 m22 m22 m

Inventories

1.4 b1.4 b1.6 b1.5 b1.5 b1.5 b

Accounts Payable

278 m306 m241 m210 m224 m231 m
USDY, 2017

Revenue/Employee

141 k

Financial Leverage

4.5 x
Show all financial metrics

Zoetis Market Value History

Zoetis Median Salaries

Source: 54 public H-1B filings from Zoetis

Zoetis's Web-traffic and Trends

Zoetis Online and Social Media Presence

Zoetis News and Updates

Veterinary/Animal Vaccines Market 2017- Global Industry Analysis, Size, Share, Growth, Trends and Forecast by 2022

Wiseguyreports.Com Adds “Veterinary/Animal Vaccines-Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Animal Healthcare Market: Global Key Players, Trends, Share, Industry Size, Growth, Opportunities, Forecast To 2022

Wiseguyreports.Com Adds “Animal Healthcare-Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Veterinary Respiratory Disease Treatment Market Value Share, Analysis and Segments 2016-2026

Future Market Insights has announced the addition of the “Veterinary Respiratory Disease Treatment Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Zoetis Company Life and Culture

You may also be interested in